Author:
Akimoto Susumu,Ohki Takemasa,Akakura Koichiro,Masai Motoyuki,Shimazaki Jun
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference22 articles.
1. Akimoto S, Akakura K, Masai M, Shimazaki J (1991) Response to chemotherapy in endocrine therapy-relapsed and-resistant prostate cancer. Acta Urol Jpn 37:31
2. Akimoto S, Masai M, Kitagawa N, Nakamura T, Shimazaki J (1993) Determinations of tumor marker doubling time in the patients with prostate cancer relapsed from endocrine therapy. Jpn J Urol 84:450
3. Babaian RJ, Hsu SD (1984) Chemotherapy of hormone-refractory carcinoma of prostate with 5-fluorouracil, adriamycin, and mitomycin C. Urology 23:272
4. Blumenstein B, Crawford ED, Saiers JH, Stephens RL, Rivkin SE, Coltman CA Jr (1993) Doxorubicin, mitomycin C and 5-fluorouracil in the treatment of hormone refractory adenocarcinoma of the prostate: a Southwest Oncology Group study. J Urol 150:411
5. Dexeus F, Logothetis CJ, Samuels ML, Hossan E, Eshenbach AC von (1985) Continuous infusion of vinblastine for advanced hormone-refractory prostate cancer. Cancer Treat Rep 69:885
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献